← All diseases
Brain and nervous system
Multiple sclerosis (progressive)
Do you want to receive a message when there is new research on Multiple Sclerosis (Progressive)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you see one sentence explaining what was investigated — and you'll be notified as soon as new research on Multiple sclerosis (progressive) is published. View what Premium costs.
Publications and studies (1542)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nutrients and bioactive compounds as modifiers of neurodegenerative trajectories: molecular mechanisms, translational barriers, and precision nutrition. (2026/06/03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effects of supervised progressive resistance training on corticospinal excitability in persons with multiple sclerosis: A randomized controlled trial protocol for the NEXIMS study. (2026/06/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study. (2026/05/21) ♡
- Immunoregulatory Effect of Curcumin on Experimental Autoimmune Encephalomyelitis (EAE), an Animal Model of Multiple Sclerosis (MS). (2026/05/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autologous Stem Cell Transplantation for Multiple Sclerosis. (2026/05/01) ♡
- Counteracting inactivity deconditioning with graded hypergravity loading: From clinical neurorehabilitation to space medicine. (2026/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. T cell-mediated immunodysregulation in multiple sclerosis: from pathogenic subsets to therapeutic advances. (2026/04/15) ♡
- Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosis. (2026/04/03) ♡
- Allergic phenotypes and asthma in multiple sclerosis: Epidemiologic and genetic relationships. (2026/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploring Sex-Based Mechanisms of Inflammation and Neurodegeneration in Multiple Sclerosis. (2026/04/01) ♡
- Determinants of change in disease-modifying drugs in patients with multiple sclerosis: A registry-based study. (2026/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anti-aging and Anti-inflammatory Dietary Interventions in Multiple Sclerosis: A Narrative Review. (2026/04/01) ♡
- Clopidogrel modulate deregulated metabolic pathways in cuprizone fed mice model of Multiple Sclerosis. (2026/04/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Vitamin D status, supplementation, and multiple sclerosis: a systematic review and meta-analysis. (2026/03/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives. (2026/03/26) ♡
- Mitochondrial transplantation ameliorates experimental autoimmune encephalomyelitis by modulating the Th17/Treg balance and restoring metabolic homeostasis. (2026/03/16) ♡
- Kikuchi-Fujimoto Disease Presenting With Complex Neurological Manifestations: A Case Report. (2026/03/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Redefining multiple sclerosis with CAR-T cell therapy. (2026/03/04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Enterovirus Encephalitis in People With Multiple Sclerosis on Ocrelizumab: Insights From a Multicenter Case Series. (2026/03/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Putative Tissue-Based Biomarkers of Male Genital Lichen Sclerosus-A Systematic Literature Review. (2026/03/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Efficacy and tolerability of metformin as an adjuvant therapy in patients with relapse-remitting multiple sclerosis receiving interferon Beta 1a: A randomized pilot trial. (2026/03/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Effects of exercise training on some cytokine profiles in patients with multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Impact of the Combination of Epigallocatechin Gallate and Ellagic Acid Supplemented with Ketone Bodies on Energetic Restoration of Mitochondrial Dysfunction and Metabolic Inefficiencies in Patients with Multiple Sclerosis: A Review. (2026/02/25) ♡
- Preventing physical and chemical degradation of the LABL-Fc-MOG(R5), a bifunctional peptide inhibitor, with formulation development approaches. (2026/02/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Diet-Multiple Sclerosis Connection: Oxidative Stress and Emerging Mechanisms. (2026/02/18) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Misfolding protein pathology detected in a chronic mouse model of multiple sclerosis. (2026/02/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Lifestyle Factors in Multiple Sclerosis: An Integrative Perspective. (2026/02/13) ♡
- Patient-reported gradual worsening reveals progression beyond MS subtypes. (2026/02/07) ♡
- Early response in cytokine and miR-124a, -125b, -223 expression to anti-CD20 in Multiple Sclerosis and its animal model - a preliminary analysis. (2026/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Impact of ocrelizumab on quality of life, fatigue, and depression among multiple sclerosis patients. (2026/02/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Towards practical management of the Marburg variant of multiple sclerosis. (2026/02/01) ♡
- Usage and limitations of neuroglial biomarkers NfL and GFAP in urine as non-invasive disease markers in multiple sclerosis. (2026/02/01) ♡
- Employment status in people with multiple sclerosis: Profile, dynamic changes and determinants over time. (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Housing needs for people with multiple sclerosis: a rapid review. (2026/02/01) ♡
- Association of Brain Age With Physical Disability and Cognitive Impairment in People With Multiple Sclerosis of the Same Age. (2026/01/27) ♡
- Experience of using anti-CD 20 therapies in multiple sclerosis patients in Kenya. (2026/01/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metallothioneins in Neurodegenerative Diseases: Metal Homeostasis, Autoimmunity, and Therapeutic Potential. (2026/01/19) ♡
- Siponimod enhances brain-derived neurotrophic factor secretion from immune cells in multiple sclerosis: A longitudinal study. (2026/01/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Glutathione and neurodegenerative diseases: immunopharmacological implications. (2026/01/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bioactive Phytochemicals in Experimental Models of Multiple Sclerosis: Mechanisms, Efficacy, and Translational Potential. (2026/01/15) ♡
- Cardiorespiratory fitness does not predict longitudinal changes in manual dexterity, cognition or corticospinal excitability in multiple sclerosis. (2026/01/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dual role of exosomes in neurodegenerative diseases: a molecular bridge between neuroinflammation and transmission of pathological proteins. (2026/01/14) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial. (2026/01/13) ♡
- Apolipoprotein A1 reduces blood-spinal cord barrier leakage, improves astrocytic coverage, and enhances motor neuron survival to restore the neurovascular unit in ALS mice. (2026/01/12) ♡
- A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis. (2026/01/08) ♡
- ATH-1105 mitigates multiple pathologies in ALS models both alone and in combination with riluzole. (2026/01/08) ♡
- NEDA-3 using cladribine for multiple sclerosis: effectiveness data from a Norwegian hospital. (2026/01/05) ♡
- Disproportionality analysis of drug-associated progressive multifocal leukoencephalopathy: roles of underlying diseases and immunomodulatory therapies in FAERS. (2026/01/02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effectiveness of rituximab in the treatment of multiple sclerosis: A multicenter, retrospective, observational study in morocco. (2026/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1β signaling. (2026/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.